Clinical Trial Update: Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response. [NA]

View source ↗

Summary

A completed trial assessed whether adding Triiodothyronine (T3) and Reboxetine to sertraline improves efficacy in major depressive disorder, including safety an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Reboxetine (Reboxetine)
• Sertraline (Sertraline)
• Triiodothyronine (liothyronine sodium)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Major Depressive Disorder | NA | Status: COMPLETED